Loading…
Reported covered position: Director, Federal Government Affairs
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Promoting Innovation and Access to Life-Saving Medicine Act
Client: F HOFFMANN-LA ROCHE LTD AND ITS AFFILIATES · Firm: F. HOFFMANN-LA ROCHE LTD, AND ITS AFFILIATES
Pandemic preparedness; Accutane safety; diabetes issues; Tamiflu; Reimbursement and other issues related to anemia and arthritis drugs. Planning treatment protocols for patiens requireing cancer drugs; issues related to government purchases of pandemic drugs; community relations and outreach to develop and maintain relationships with minority groups and health organizations to promote diabetes awareness. Public policy such as promoting initiatives and strategizing on the most effective approaches to tell the story of Roche's efforts to address and try to resolve health disparities affecting minority communities. Addressed funding for pandemic flu and emergency preparedness. H.R. 1585, The FIT Kids Act, issues addressing childhood obesity; addressed issues pertaining to comprehensive health care reform; comparative effectiveness research. S.1213, Patient-Centered outcomes Research Act of 2009 and S. 3408, H.R.1548, Pathway for Biosimilars Act; and S. 525, Pharmaceutical Market Access & Drug Safety Act of 2009. Track and monitor health care reform including H.R. 1427 and S. 726, Promoting Innovation and Access to Life-Saving Medicince Act General support for Hoffmann-LaRoche products.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
F HOFFMANN-LA ROCHE LTD AND ITS AFFILIATES via F. HOFFMANN-LA ROCHE LTD, AND ITS AFFILIATES
2009 · fourth_quarter · Q4
Advocate on legislative changes regarding biosimilars; pandemic preparedness, health reform, health care reform legislation, including safety and data exclusivity issues regarding follow-on biologics; policy analysis; address concerns regarding the federal government's purchase and stockpiling of Tamiflu; HR 3200 America's Affordable Health Choices Act: and the America's Healthy Future Act of 2009; H.R. 1 - Pandemic influenza funding; H.R. 1105 Omnibus Appropriations Act; Pandemic funding issues; FY10 Labor HHS Appropriations legislation: H.R. 2346 Supplemental Appropriations Act of 2009 Congress and Federal Agencies; community relations and outreach to develop and maintain relationships with minority groups and health organizations; Public policy such as developming strategies on the most effective approaches to tell the story of Roche's efforts to address and try to resolve health disparities affecting minority communities.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Personnel Management (OPM), SENATE, Veterans Affairs, Dept of (VA)
Source: Senate LDA
Pathway for Biosimilars Act
Client: F HOFFMANN-LA ROCHE LTD AND ITS AFFILIATES · Firm: F. HOFFMANN-LA ROCHE LTD, AND ITS AFFILIATES
Pandemic preparedness; Accutane safety; diabetes issues; Tamiflu; Reimbursement and other issues related to anemia and arthritis drugs. Planning treatment protocols for patiens requireing cancer drugs; issues related to government purchases of pandemic drugs; community relations and outreach to develop and maintain relationships with minority groups and health organizations to promote diabetes awareness. Public policy such as promoting initiatives and strategizing on the most effective approaches to tell the story of Roche's efforts to address and try to resolve health disparities affecting minority communities. Addressed funding for pandemic flu and emergency preparedness. H.R. 1585, The FIT Kids Act, issues addressing childhood obesity; addressed issues pertaining to comprehensive health care reform; comparative effectiveness research. S.1213, Patient-Centered outcomes Research Act of 2009 and S. 3408, H.R.1548, Pathway for Biosimilars Act; and S. 525, Pharmaceutical Market Access & Drug Safety Act of 2009. Track and monitor health care reform including H.R. 1427 and S. 726, Promoting Innovation and Access to Life-Saving Medicince Act General support for Hoffmann-LaRoche products.
FIT Kids Act
Client: F HOFFMANN-LA ROCHE LTD AND ITS AFFILIATES · Firm: F. HOFFMANN-LA ROCHE LTD, AND ITS AFFILIATES
Pandemic preparedness; Accutane safety; diabetes issues; Tamiflu; Reimbursement and other issues related to anemia and arthritis drugs. Planning treatment protocols for patiens requireing cancer drugs; issues related to government purchases of pandemic drugs; community relations and outreach to develop and maintain relationships with minority groups and health organizations to promote diabetes awareness. Public policy such as promoting initiatives and strategizing on the most effective approaches to tell the story of Roche's efforts to address and try to resolve health disparities affecting minority communities. Addressed funding for pandemic flu and emergency preparedness. H.R. 1585, The FIT Kids Act, issues addressing childhood obesity; addressed issues pertaining to comprehensive health care reform; comparative effectiveness research. S.1213, Patient-Centered outcomes Research Act of 2009 and S. 3408, H.R.1548, Pathway for Biosimilars Act; and S. 525, Pharmaceutical Market Access & Drug Safety Act of 2009. Track and monitor health care reform including H.R. 1427 and S. 726, Promoting Innovation and Access to Life-Saving Medicince Act General support for Hoffmann-LaRoche products.
America's Affordable Health Choices Act of 2009
Client: F HOFFMANN-LA ROCHE LTD AND ITS AFFILIATES · Firm: F. HOFFMANN-LA ROCHE LTD, AND ITS AFFILIATES
Advocate on legislative changes regarding biosimilars; pandemic preparedness, health reform, health care reform legislation, including safety and data exclusivity issues regarding follow-on biologics; policy analysis; address concerns regarding the federal government's purchase and stockpiling of Tamiflu; HR 3200 America's Affordable Health Choices Act: and the America's Healthy Future Act of 2009; H.R. 1 - Pandemic influenza funding; H.R. 1105 Omnibus Appropriations Act; Pandemic funding issues; FY10 Labor HHS Appropriations legislation: H.R. 2346 Supplemental Appropriations Act of 2009 Congress and Federal Agencies; community relations and outreach to develop and maintain relationships with minority groups and health organizations; Public policy such as developming strategies on the most effective approaches to tell the story of Roche's efforts to address and try to resolve health disparities affecting minority communities.
America's Affordable Health Choices Act of 2009
Client: F HOFFMANN-LA ROCHE LTD AND ITS AFFILIATES · Firm: F. HOFFMANN-LA ROCHE LTD, AND ITS AFFILIATES
Pandemic preparedness; accutane safety; general diabetes and pharmaceutical issues; health care reform legislation; H.R. 3200, America Affordable Health Choices Act; and the America's Health Future Act of 2009; Community Relations and Outreach to develop and maintain relationships with minority groups and health organizations to promote diabetes awareness. Developing strategies on the most effective approaches to address and try to resolve health disparities affecting minority communities General healthcare issues - biosimilars.
Patient-Centered Outcomes Research Act of 2009
Client: F HOFFMANN-LA ROCHE LTD AND ITS AFFILIATES · Firm: F. HOFFMANN-LA ROCHE LTD, AND ITS AFFILIATES
Pandemic preparedness; Accutane safety; diabetes issues; Tamiflu; Reimbursement and other issues related to anemia and arthritis drugs. Planning treatment protocols for patiens requireing cancer drugs; issues related to government purchases of pandemic drugs; community relations and outreach to develop and maintain relationships with minority groups and health organizations to promote diabetes awareness. Public policy such as promoting initiatives and strategizing on the most effective approaches to tell the story of Roche's efforts to address and try to resolve health disparities affecting minority communities. Addressed funding for pandemic flu and emergency preparedness. H.R. 1585, The FIT Kids Act, issues addressing childhood obesity; addressed issues pertaining to comprehensive health care reform; comparative effectiveness research. S.1213, Patient-Centered outcomes Research Act of 2009 and S. 3408, H.R.1548, Pathway for Biosimilars Act; and S. 525, Pharmaceutical Market Access & Drug Safety Act of 2009. Track and monitor health care reform including H.R. 1427 and S. 726, Promoting Innovation and Access to Life-Saving Medicince Act General support for Hoffmann-LaRoche products.
Nevada Mining Townsite Conveyance Act
Client: F HOFFMANN-LA ROCHE LTD AND ITS AFFILIATES · Firm: F. HOFFMANN-LA ROCHE LTD, AND ITS AFFILIATES
Pandemic preparedness; Accutane safety; diabetes issues; Tamiflu; Reimbursement and other issues related to anemia and arthritis drugs. Planning treatment protocols for patiens requireing cancer drugs; issues related to government purchases of pandemic drugs; community relations and outreach to develop and maintain relationships with minority groups and health organizations to promote diabetes awareness. Public policy such as promoting initiatives and strategizing on the most effective approaches to tell the story of Roche's efforts to address and try to resolve health disparities affecting minority communities. Addressed funding for pandemic flu and emergency preparedness. H.R. 1585, The FIT Kids Act, issues addressing childhood obesity; addressed issues pertaining to comprehensive health care reform; comparative effectiveness research. S.1213, Patient-Centered outcomes Research Act of 2009 and S. 3408, H.R.1548, Pathway for Biosimilars Act; and S. 525, Pharmaceutical Market Access & Drug Safety Act of 2009. Track and monitor health care reform including H.R. 1427 and S. 726, Promoting Innovation and Access to Life-Saving Medicince Act General support for Hoffmann-LaRoche products.
Pharmaceutical Market Access and Drug Safety Act of 2009
Client: F HOFFMANN-LA ROCHE LTD AND ITS AFFILIATES · Firm: F. HOFFMANN-LA ROCHE LTD, AND ITS AFFILIATES
Pandemic preparedness; Accutane safety; diabetes issues; Tamiflu; Reimbursement and other issues related to anemia and arthritis drugs. Planning treatment protocols for patiens requireing cancer drugs; issues related to government purchases of pandemic drugs; community relations and outreach to develop and maintain relationships with minority groups and health organizations to promote diabetes awareness. Public policy such as promoting initiatives and strategizing on the most effective approaches to tell the story of Roche's efforts to address and try to resolve health disparities affecting minority communities. Addressed funding for pandemic flu and emergency preparedness. H.R. 1585, The FIT Kids Act, issues addressing childhood obesity; addressed issues pertaining to comprehensive health care reform; comparative effectiveness research. S.1213, Patient-Centered outcomes Research Act of 2009 and S. 3408, H.R.1548, Pathway for Biosimilars Act; and S. 525, Pharmaceutical Market Access & Drug Safety Act of 2009. Track and monitor health care reform including H.R. 1427 and S. 726, Promoting Innovation and Access to Life-Saving Medicince Act General support for Hoffmann-LaRoche products.
Promoting Innovation and Access to Life-Saving Medicine Act
Client: F HOFFMANN-LA ROCHE LTD AND ITS AFFILIATES · Firm: F. HOFFMANN-LA ROCHE LTD, AND ITS AFFILIATES
Pandemic preparedness; Accutane safety; diabetes issues; Tamiflu; Reimbursement and other issues related to anemia and arthritis drugs. Planning treatment protocols for patiens requireing cancer drugs; issues related to government purchases of pandemic drugs; community relations and outreach to develop and maintain relationships with minority groups and health organizations to promote diabetes awareness. Public policy such as promoting initiatives and strategizing on the most effective approaches to tell the story of Roche's efforts to address and try to resolve health disparities affecting minority communities. Addressed funding for pandemic flu and emergency preparedness. H.R. 1585, The FIT Kids Act, issues addressing childhood obesity; addressed issues pertaining to comprehensive health care reform; comparative effectiveness research. S.1213, Patient-Centered outcomes Research Act of 2009 and S. 3408, H.R.1548, Pathway for Biosimilars Act; and S. 525, Pharmaceutical Market Access & Drug Safety Act of 2009. Track and monitor health care reform including H.R. 1427 and S. 726, Promoting Innovation and Access to Life-Saving Medicince Act General support for Hoffmann-LaRoche products.
Physician Pathology Services Continuity Act of 2007
Client: F HOFFMANN-LA ROCHE LTD AND ITS AFFILIATES · Firm: F. HOFFMANN-LA ROCHE LTD, AND ITS AFFILIATES
Advocate on legislative changes regarding biosimilars; pandemic preparedness, health reform, health care reform legislation, including safety and data exclusivity issues regarding follow-on biologics; policy analysis; address concerns regarding the federal government's purchase and stockpiling of Tamiflu; HR 3200 America's Affordable Health Choices Act: and the America's Healthy Future Act of 2009; H.R. 1 - Pandemic influenza funding; H.R. 1105 Omnibus Appropriations Act; Pandemic funding issues; FY10 Labor HHS Appropriations legislation: H.R. 2346 Supplemental Appropriations Act of 2009 Congress and Federal Agencies; community relations and outreach to develop and maintain relationships with minority groups and health organizations; Public policy such as developming strategies on the most effective approaches to tell the story of Roche's efforts to address and try to resolve health disparities affecting minority communities.
F HOFFMANN-LA ROCHE LTD AND ITS AFFILIATES via F. HOFFMANN-LA ROCHE LTD, AND ITS AFFILIATES
2009 · third_quarter · Q3
Pandemic preparedness; accutane safety; general diabetes and pharmaceutical issues; health care reform legislation; H.R. 3200, America Affordable Health Choices Act; and the America's Health Future Act of 2009; Community Relations and Outreach to develop and maintain relationships with minority groups and health organizations to promote diabetes awareness. Developing strategies on the most effective approaches to address and try to resolve health disparities affecting minority communities General healthcare issues - biosimilars.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
F HOFFMANN-LA ROCHE LTD AND ITS AFFILIATES via F. HOFFMANN-LA ROCHE LTD, AND ITS AFFILIATES
2009 · second_quarter · Q2
Pandemic preparedness; Accutane safety; diabetes issues; Tamiflu; Reimbursement and other issues related to anemia and arthritis drugs. Planning treatment protocols for patiens requireing cancer drugs; issues related to government purchases of pandemic drugs; community relations and outreach to develop and maintain relationships with minority groups and health organizations to promote diabetes awareness. Public policy such as promoting initiatives and strategizing on the most effective approaches to tell the story of Roche's efforts to address and try to resolve health disparities affecting minority communities. Addressed funding for pandemic flu and emergency preparedness. H.R. 1585, The FIT Kids Act, issues addressing childhood obesity; addressed issues pertaining to comprehensive health care reform; comparative effectiveness research. S.1213, Patient-Centered outcomes Research Act of 2009 and S. 3408, H.R.1548, Pathway for Biosimilars Act; and S. 525, Pharmaceutical Market Access & Drug Safety Act of 2009. Track and monitor health care reform including H.R. 1427 and S. 726, Promoting Innovation and Access to Life-Saving Medicince Act General support for Hoffmann-LaRoche products.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE